National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting, 52076-52077 [E6-14556]

Download as PDF 52076 Federal Register / Vol. 71, No. 170 / Friday, September 1, 2006 / Notices Board of Governors of the Federal Reserve System, August 28, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6–14505 Filed 8–31–06; 8:45 am] Board of Governors of the Federal Reserve System, August 28, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6–14504 Filed 8–31–06; 8:45 am] BILLING CODE 6210–01–S BILLING CODE 6210–01–S FEDERAL RESERVE SYSTEM DEPARTMENT OF HEALTH AND HUMAN SERVICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies sroberts on PROD1PC70 with NOTICES The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than September 25, 2006. A. Federal Reserve Bank of Richmond (A. Linwood Gill, III, Vice President) 701 East Byrd Street, Richmond, Virginia 23261-4528: 1. First Charter Corporation, Charlotte, North Carolina; to acquire 100 percent of the voting shares of GBC Bancorp, Inc., and thereby indirectly acquire Gwinnett Banking Company, both of Lawrenceville, Georgia. VerDate Aug<31>2005 16:21 Aug 31, 2006 Jkt 208001 Office of the National Coordinator; American Health Information Community Biosurveillance Data Steering Group Meeting ACTION: Announcement of meeting. SUMMARY: This notice announces the fifth meeting of the American Health Information Community Biosurveillance Data Steering Group in accordance with the Federal Advisory Committee Act (Pub. L. 92–463, 5 U.S.C., App.). DATES: September 5, 2006, 2 to 4 p.m. ADDRESSES: Mary C. Switzer Building (330 C Street, SW., Washington, DC 20201), Conference Room 4090. [Please bring photo ID for entry to a Federal building.] FOR FURTHER INFORMATION CONTACT: https://www.hhs.gov/healthit/ahic/ bio_main.html. The meeting will be available via Web cast at https://www.eventcenterlive.com/ cfmx/ec/logic/login1.cfm?BID=67. SUPPLEMENTARY INFORMATION: Dated: August 23, 2006. Judith Sparrow, Director, American Health Information Community, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology. [FR Doc. 06–7379 Filed 8–31–06; 8:45 am] BILLING CODE 4150–24–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the National Coordinator for Health Information Technology; American Health Information Community Biosurveillance Data Steering Group Meeting ACTION: Announcement of meeting. SUMMARY: This notice announces the sixth meeting of the American Health Information Community Biosurveillance Data Steering Group in accordance with the Federal Advisory Committee Act (Pub. L. 92–463, 5 U.S.C., App.). DATES: September 14, 2006 from 1:30 p.m. to 4:30 p.m. PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 Mary C. Switzer Building (330 C Street, SW., Washington, DC 20201), Conference Room 4090 (you will need a photo ID to enter a Federal building). FOR FURTHER INFORMATION CONTACT: https://www.hhs.gov/healthit/ahic/ bio_main.html. ADDRESSES: The meeting will be available via Internet access. Go to https://www.hhs.gov/ healthit/ahic/bio_instruct.html for additional information on the meeting. SUPPLEMENTARY INFORMATION: Dated: August 25, 2006. Judith Sparrow, Director, American Health Information Community, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology. [FR Doc. 06–7380 Filed 8–31–06; 8:45 am] BILLING CODE 4150–24–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), National Center on Birth Defects and Developmental Disabilities (NCBDDD) announces the following meeting. Name: National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE). Times and Dates: September 26, 2006, 8:30 a.m.–4:30 p.m.; September 27, 2006, 8:30 a.m.–1 p.m. Place: Doubletree Atlanta Buckhead, 3342 Peachtree Road, NE., Atlanta, Georgia 30326, telephone 404 231–1234, fax 404 231–3112. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 80 people. Purpose: The Secretary is authorized by the Public Health Service Act, Section 399G, (42 U.S.C. Section 280f, as added by Public Law 105–392) to establish a National Task Force on Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effect (FAE) to: (1) Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support FAS and FAE research, programs and surveillance; and (2) to otherwise meet the general needs of E:\FR\FM\01SEN1.SGM 01SEN1 Federal Register / Vol. 71, No. 170 / Friday, September 1, 2006 / Notices populations actually or potentially impacted by FAS and FAE. Matters to be Discussed: Agenda items include: Overview of recent research on innovative approaches to help in identification and diagnosis of FAS and other alcohol-related neurodevelopmental disorders, update on Task Force report of evidence-based review of fetal alcohol spectrum disorders prevention strategies; updates from the Interagency Coordinating Committee on Fetal Alcohol Syndrome, the CDC and other Federal agencies, and liaison representatives; and scheduling of the next meeting. Agenda items are subject to change as priorities dictate. For Further Information Contact: Mary Kate Weber, M.P.H., Designated Federal Official, National Center on Birth Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E–86), Atlanta, Georgia 30333, telephone 404 498–3926, fax 404 498– 3550. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: August 28, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–14556 Filed 8–31–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sroberts on PROD1PC70 with NOTICES ICD–9–CM Coordination and Maintenance Committee Meeting The National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting. Name: ICD–9–CM Coordination and Maintenance Committee meeting. Times and Dates: 9 a.m.–5 p.m., September 28–29, 2006. Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland. Status: Open to the public. Purpose: The ICD–9–CM Coordination and Maintenance (C&M) Committee will hold its final meeting of the 2006 calendar year cycle on Thursday and Friday, September 28–29, 2006. The VerDate Aug<31>2005 16:21 Aug 31, 2006 Jkt 208001 C&M meeting is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Ninth-Revision, Clinical Modification. Matters To Be Discussed: Tentative agenda items include: Abnormal cytology of vagina, Acquired absence of cervix/uterus, Acquired pure red cell aplasia, Antenatal screening, Avian (bird) flu, Disorder/Disease of stomach index entries, E code for Fosamax and similar compounds, Fetal medicine, Harmful algae bloom, Hearing loss and speech language problems, History of stroke without residual deficits/TIA, Human Parvovirus, In vitro treatment status, Malignant ascites, Myotonic disorders, Osteonecrosis of jaw, drug induced, Personal history of sudden cardiac arrest (cardiac arrhythmia), Personal history of cervical dysplasia, Screening for HPV, Secondary Diabetes Mellitus (updated proposal), Septic embolism, TORCH infections, Total occlusion of peripheral vessel, Urinary risk factors, VIN and VAIN (Continuation), Addenda (diagnosis), Blood Brain Barrier, Coflex interspinous stabilization device, Intracranial Pressure (ICP) Monitoring and Oxygen Monitoring, Motion Preserving Technologies, NeuroThera TM: Non-invasive Ischemic Stroke Therapy, Pelvic Prolapse Repair, Rheos Baroreflex Activating System, Spy intraoperative fluorescence vascular angiography, Thoracoscopic procedures, TOPS TM Facet Replacement, Addenda (procedures), ICD–10–PCS. Contact Person for Additional Information: Amy Blum, Medical Systems Specialist, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road, Room 2402, Hyattsville, Maryland 20782, e-mail alb8@cdc.gov, telephone 301–458–4106 (diagnosis), Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Blvd., Baltimore, Maryland 21244, e-mail Marilu.Hue@cms.hhs.gov, telephone 410–786–4510 (procedures). PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 52077 Notice: Because of increased security requirements CMS has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show an official form of picture I.D., (such as a drivers license), and sign-in at the security desk upon entering the building. Those who wish to attend a specific ICD–9–CM C&M meeting in the CMS auditorium must submit their name and organization for addition to the meeting visitor list. Those wishing to attend the September 28–29, 2006 meeting must submit their name and organization by September 25, 2006 for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Those who attended previous ICD–9– CM C&M meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you attend. Register to attend the meeting on-line at: https://cms.hhs.gov/events. Notice: This is a public meeting. However, because of fire code requirements, should the number of attendants meet the capacity of the room, the meeting will be closed. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: August 28, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–14557 Filed 8–31–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Health Statistics In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) announces the following committee meeting. Name: Board of Scientific Counselors (BSC), NCHS. E:\FR\FM\01SEN1.SGM 01SEN1

Agencies

[Federal Register Volume 71, Number 170 (Friday, September 1, 2006)]
[Notices]
[Pages 52076-52077]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-14556]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol 
Effect: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), National Center on Birth Defects and Developmental 
Disabilities (NCBDDD) announces the following meeting.
    Name: National Task Force on Fetal Alcohol Syndrome and Fetal 
Alcohol Effect (NTFFASFAE).
    Times and Dates: September 26, 2006, 8:30 a.m.-4:30 p.m.; September 
27, 2006, 8:30 a.m.-1 p.m.
    Place: Doubletree Atlanta Buckhead, 3342 Peachtree Road, NE., 
Atlanta, Georgia 30326, telephone 404 231-1234, fax 404 231-3112.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 80 people.
    Purpose: The Secretary is authorized by the Public Health Service 
Act, Section 399G, (42 U.S.C. Section 280f, as added by Public Law 105-
392) to establish a National Task Force on Fetal Alcohol Syndrome (FAS) 
and Fetal Alcohol Effect (FAE) to: (1) Foster coordination among all 
governmental agencies, academic bodies and community groups that 
conduct or support FAS and FAE research, programs and surveillance; and 
(2) to otherwise meet the general needs of

[[Page 52077]]

populations actually or potentially impacted by FAS and FAE.
    Matters to be Discussed: Agenda items include: Overview of recent 
research on innovative approaches to help in identification and 
diagnosis of FAS and other alcohol-related neurodevelopmental 
disorders, update on Task Force report of evidence-based review of 
fetal alcohol spectrum disorders prevention strategies; updates from 
the Interagency Coordinating Committee on Fetal Alcohol Syndrome, the 
CDC and other Federal agencies, and liaison representatives; and 
scheduling of the next meeting. Agenda items are subject to change as 
priorities dictate.
    For Further Information Contact: Mary Kate Weber, M.P.H., 
Designated Federal Official, National Center on Birth Defects and 
Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E-86), 
Atlanta, Georgia 30333, telephone 404 498-3926, fax 404 498-3550.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: August 28, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-14556 Filed 8-31-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.